Lee John Y K, Bohman Leif-Erik, Bergsneider Marvin
Department of Neurosurgery, University of Pennsylvania, Washington Square West Building, 235 S. 8th Street, Philadelphia, PA, 19106, USA,
J Neurooncol. 2014 May;117(3):437-44. doi: 10.1007/s11060-013-1315-z. Epub 2013 Nov 22.
Approximately 5,000 trans-sphenoidal surgeries are performed for resection of pituitary tumors each year in the United States. The rise in popularity of the trans-spehnoidal approach, though described nearly a century ago, has been facilitated over the last decades by advances in technique and technology. In this review, we discuss the relative strengths of microscopic and endoscopic techniques for pituitary tumor resection. However, despite being the standard of care for patients with most pituitary tumors, cure rates for many subtypes of pituitary lesions, such as secretory macroadenomas or tumors with significant cavernous sinus invasion, remain unsatisfactory. We also describe two more recent advances in neurosurgical technique which may offer promise of increased rates of surgical cure: pseudocapsular resection and cavernous sinus approaches.
在美国,每年约有5000例经蝶窦手术用于切除垂体肿瘤。经蝶窦入路的 popularity 虽在近一个世纪前就已被描述,但在过去几十年中,技术和科技的进步推动了其普及。在本综述中,我们讨论了显微镜和内镜技术在垂体肿瘤切除中的相对优势。然而,尽管经蝶窦手术是大多数垂体肿瘤患者的标准治疗方法,但许多垂体病变亚型,如分泌性大腺瘤或伴有海绵窦显著侵犯的肿瘤,其治愈率仍不尽人意。我们还描述了神经外科技术的另外两项最新进展,它们可能有望提高手术治愈率:假包膜切除术和海绵窦入路。